PROVENTA INTERNATIONAL. INNOVATION SPOTLIGHT SESSION 0pen Source Technologies for Precision Medicine
|
|
- Nelson Pierce
- 8 years ago
- Views:
Transcription
1 INNOVATION SPOTLIGHT SESSION 0pen Source Technologies for Precision Medicine WEDNESDAY 3RD JUNE 2015 The Marriott Heathrow, London PROVENTA INTERNATIONAL
2 INNOVATION INNOVATION SPOTLIGHT The focus of this Innovation Spotlight Session is the challenge of building a comprehensive and sustainable open source platform and community for Precision Medicine Informatics. The attendees are pharma R&D IT executives, academic PI s and MD s who share a common vision that today s biomedical informatics challenges should be and in certain regards can only be met by pre-competitive collaboration. The sponsor of this meeting, The Hyve, is a global open source software service company with a mission to make open source the de facto standard for R&D IT in the life sciences. The case study for this meeting is an intersection of a suite of open source software applications for translational research, including transmart, cbioportal, ADAM and Galaxy, with a few public datasets such as TCGA, ADNI and CCLE. Speakers will highlight various viewpoints from their own experience (pharma IT, academic research and clinical application). In a number of focused roundtable sessions specific challenges will be addressed, such as the the business model for collaborative annotation of public data, the prerequisites for integrating open source software in an enterprise pharma IT landscape, and the relevant visualization techniques for navigating clinical and biomarker data. Online Community Our online community enables roundtable discussions to be prolonged and shared globally in a pre-competetive environment. We keep leaders constantly informed with the latest updates in a user friendly platform. Telephone:
3 SPOTLIGHT SESSION 2015 IN PARTNERSHIP WITH KEY OPINION LEADERS Prof. Gerrit Meijer Professor of Pathology Netherlands Cancer Institute Kees van Bochove CEO The Hyve Paul Avillach Assistant Professor Harvard Medical School Nikolaus Schultz Associate Attending Computational Oncologist Memorial Sloan Kettering Cancer Center Jay Bergeron Director, Translational and Bioinformatics Pfizer Sjoerd van Hagen Software Engineer The Hyve Jan-Willem Boiten Project Manager Translation Research IT CTMM Jean-Baptiste Cazier Director of Centre for Computational Biology, Prof of Bioinformatics University of Birmingham Keith O. Elliston President and CEO transmart Foundation John Wise Executive Director Pistoia Alliance
4 TIME AGENDA ROOM 9:00-9:30 REGISTRATION HALL 9:30-9:45 Welcome Address: Kees van Bochove, CEO, The Hyve Opening Presentation: Towards a comprehensive application suite for translational research: integrating clinical, imaging, biobanking and biomarker data 09:45-10:15 Abstract: Translational research aims to bring our increasing knowledge of biology as new diagnostic and therapeutic solutions to patients, thus changing clinical practice. This requires solid evidence, coming from high quality studies that integrate disease phenotype and readouts of biology. For this purpose, originally siloed domains like clinical registries, imaging, biobanking and omics need to converge. Within the European Strategy for Research Infrastructure (ESFRI) multiple biomedical science infrastructures like BBMRI, EATRIS, and ELIXIR have taken up this challenge, e.g. in the context of the BioMedBridges program. Speaker: Prof. Gerrit Meijer, Professor of Pathology, Netherlands Cancer Institute 10:15-10:45 Case Study: Toward Precision Medicine: Building a patient centric information commons on common and rare diseases with transmart Abstract: TranSMART is used today at Harvard Medical School as a comprehensive clinical and genomic database for enabling a multidimensional perspective of autism spectrum disorder and Phelan- McDermid Syndrome (n=1100 patients worldwide). Paul will show a live demo to illustrate how his group integrates various sources such as Registry data, Patient reported outcome, longitudinal EHR, Patient consent, Biobank, Exome sequencing data and knowledge from Clinical notes for discovery and analysis. Moderator: Paul Avillach, Assistant Professor, Harvard Medical School 10:45-11:15 Morning Break HALL 11:15-11:45 Presentation: Imitation and Disruption: The impact of Open Source Software in the Life Sciences Abstract: There are many successful examples of open source software (OSS) both within and outside of the life sciences community. However, investigators sponsoring software-based efforts need to consider many factors, including resourcing, architecture fragmentation, maintenance and their customer community when selecting between commercial and open license alternatives. This presentation will review the factors involved in successful open source collaborations including business models and socio-psychological factors, and will focus on the IMI etriks translational infrastructure project as an example. Speaker: Jay Bergeron, Director, Translational and Bioinformatics, Pfizer 11:45-12:45 Roundtable Discussion: What are the prerequisites for integrating open source software in an enterprise pharma IT landscape? Abstract: What are the unique advantages of open source software in the pharma IT context? Using open-source software has many attractions; but it is not without its disadvantages. The attractions need to be clearly identified and articulated, just as the disadvantages whether real or perceived - need to be clearly understood and addressed in order to integrate open-source software in pharma IT. This round table discussion will set out to identify advantages such as: -Encouraging pre-competitive collaboration, especially with academic organisations - Lowering system implementation costs - Allowing quicker and richer functional development by exposure to wider, more varied communities But disadvantages that need to be addressed will be considered too, such as: - Perceptions of quality compared to commercial product - Difficulties in understanding the licensing terms of open-source software use and development - Change control of open-source software supporting processes in the regulated domain of the industry Moderator: John Wise, Executive Director, Pistoia Alliance 13:00-14:00 Networking Lunch HALL
5 TIME AGENDA ROOM Case Study:The cbioportal for genomics data visualization in a clinical setting 14:00-14:45 Abstract: As sequencing of tumor samples is entering clinical practice, there is an urgent need for new tools that facilitate the interpretation of sequence data so that they can effectively inform treatment decisions. The cbioportal for Cancer Genomics is a web-based visualization and analysis engine that makes complex cancer genomics data accessible to a wide range of cancer researchers and clinicians. Moderator: Nikolaus Schultz, Associate Attending Computational Oncologist, Memorial Sloan Kettering Cancer Center 15:00-16:00 Roundtable Discussion: Is there a business model for collaborative annotation of public data? Abstract: Annotation of ever larger data sets requires a tremendous effort, leading to increasing difficulty to achieve both Quality and Quantity simultaneously. Automation can go a long way, but the lack of a perfect solution implies competing approaches which in turn require manual curating. These can be just as competitive, and even sometimes contradicting. Traditionally, curation is done in parallel by academic groups as well as by vendors, paid by pharma companies. Is there an interest and a business model for a truly precompetitive effort around data curation of large public datasets such as TCGA, CCLE, GEO studies, dbgap studies etc? How would this curation work together with the Data Use Agreements of such studies? Moderator: Jean-Baptiste Cazier, Director of Centre for Computational Biology, Prof of Bioinformatics, University of Birmingham 16:00-16:15 Afternoon Break HALL Technical Exposition: ADAM: using Apache Spark to build the next-generation infrastructure for genomics data storage and compute. 16:00-16:15 Abstract: The cost of sequencing whole genomes has dropped significantly during the past decade, leading to a steep increase in the amount of available genomics data. On the phenotype side both smartphones and sensors are getting cheaper and wearables are being introduced, a development that will lead to large amounts of phenotypic data. Similar trends can be observed in other types of data. To extract knowledge from these data we need an approach that is both flexible and scalable, flexible because of the variety in the data and scalable because of the sheer size. These requirements are exactly what sparked the rise of Big Data, which was initially geared towards textual data generated by people on the internet, unstructured and big with small nuggets of knowledge hidden inside. Challenges in biology can be similar: looking for small patterns or correlations in large, semi-structured data. We will do a short introduction into Big Data technologies, how they work on a high level and how they can be applied to biology. The focus will be on Apache Spark, using ADAM as an example of how you could implement Big Data genomics. Presented by: Sjoerd van Hagen, Software Engineer, The Hyve 16:45-17:45 Roundtable Discussion: How can open source software enable public-private collaboration on real scientific research questions and datasets? Abstract: Public-private collaborations are a crucial instrument for the translation of academic innovation into practical applications benefiting patients. One of the challenges to deal with in these consortia is the data processing and data sharing infrastructure: proprietary solutions of individual institutes can often not used by other partners in a cost-effective manner. Open-source solutions may offer an attractive alternative for these collaborations, certainly in the context of complex public-private partnerships with many partners as typically seen in the EU-funded IMI program. This round table will focus on the prerequisites for successful usage of open-source software in these collaborations in terms of licensing, maturity of the software, organization of the community, and hosting. Moderator: Jan-Willem Boiten, Project manager Translation Research IT, CTMM Panel Discussion: What value does open source development bring to precision medicine? Panellist: 17:45-18:15 Prof. Gerrit Meijer, Netherlands Cancer Institute Paul Avillach, Harvard Medical School Jay Bergeron, Pfizer John Wise, Pistoia Alliance Kees van Bochove, The Hyve Keith O. Elliston, transmart Foundation 18:30 Gala Dinner
6 KEY OPINION LEADERS Jay Bergeron, Director, Translational and Bioinformatics - Pfizer Jay Bergeron is the Director, Translational and Bioinformatics at Pfizer with his team being responsible for informatics support for Clinical Research and Precision Medicine. Jay is also the Scientific Coordinator of etriks (European Translational Research and Information Knowledge Management Services), a 23M EU program to support translational data management for the IMI that uses Open Source Software (transmart) as the core system, and co-lead of the code committee of the transmart Foundation, a non profit community organizer for the Open Source transmart application. The work to be presented was conducted as part of a MBA thesis associated with faculty at the Rensselaer Polytechnic Institute. Nikolaus Schultz, Associate Attending Computational Oncologist - Memorial Sloan Kettering Cancer Center Nikolaus Schultz leads the development of the cbioportal for Cancer Genomics, a popular resource for the visualization and analysis of large-scale cancer genomics data sets. His research focuses on identifying the genomic alterations that underlie different types of cancer. He is involved in several projects of The Cancer Genome Atlas (TCGA) and is an investigator in the Stand Up To Cancer (SU2C) Prostate Cancer Dream Team. Dr. Schultz is an Associate Attending Computational Oncologist in the Department of Epidemiology and Biostatistics and an affiliate member of the Human Oncology and Pathogenesis Program. He is the Head of Knowledge Systems in the Marie-Josée and Henry R. Kravis Center for Molecular Oncology. Paul Avillach, Assistant Professor - Harvard Medical School Paul Avillach is a MD in Public Health, Epidemiology and PhD in Biomedical Informatics. Assistant Professor of Pediatrics at Harvard Medical School and is on the faculty of Boston Children s Hospital in the Children s Hospital Informatics Program His research focuses on the development of novel methods and techniques for the integration of multiple heterogeneous clinic cohorts, Electronic Health Records data and multiple types of genomics data to encompass biological observations. John Wise, Executive Director - Pistoia Alliance John Wise is an Executive Director of the Pistoia Alliance and the Programme Co-ordinator for the PRISME Forum. The Pistoia Alliance is a not-for-profit, cross-company organisation committed to lowering the barriers to innovation in Life science R&D. The PRISME Forum is a notfor-profit Pharma R&D IT leadership group focussed on the identification and palliation of hot topics, and the sharing of industry best practices. John has worked in life science R&D informatics in a variety of organizations including academia, the pharmaceutical Industry, a cancer research charity as well as in the technology supply side of the industry. This has provided him with direct, hands-on experience of delivering computer-based services across the life science R&D value chain. John graduated in physiology before obtaining a post-graduate certificate in education. Prof. Gerrit Meijer, Professor of Pathology - Netherlands Cancer Institute Gerrit Meijer is professor of pathology with a special interest in translational cancer research, focusing on the gastrointestinal tract. The work of his research group involves DNA-, RNA-, and protein-based tumor profiling using -omics techniques, in order to stratify patient groups and arrive at individually tailored therapies, as well as for biomarker development to improve colorectal cancer screening. In addition, he is involved in several national and international research infrastructure programs like CTMM TraIT, EATRIS, BBMRI and the transmart foundation. Gerrit Meijer obtained his medical degree in 1993 and his PhD in 1997, both from VU University in Amsterdam, and he was registered as a pathologist in He was appointed professor of gastrointestinal pathology in 2004, and he became Chair of the Department of Pathology in Meijer will join the Netherlands Cancer Institute early in 2015 as head of Pathology. He has published over 250 papers in peer reviewed journals. Meijer chairs the scientific council of the Dutch Cancer Society. Since 2013 he has been national co-director of the European Infrastructure for Translational Medicine (EATRIS). Sjoerd van Hagen, Software Engineer - The Hyve Sjoerd van Hagen is a highly adaptive and versatile individual who has a strong theoretical background in algorithms and takes pride in producing quality work. His love for startups and adventure has brought him in contact with a wide variety of technologies, especially in the area of Big Data. Here he also developed a keen interest in any skill useful in setting up businesses. He likes teaching and sharing knowledge and will not shy away from a good discussion. Before The Hyve, Sjoerd has obtained a master s degree in computer science at the University of Utrecht and worked at Cloudscale, a Silicon Valley startup by Bill McColl, after which he and Bill have been researching the possibility of creating a new company. At The Hyve, Sjoerd has been driving Big Data projects for a.o. a large pharmaceutical company, using ADAM, Apache Spark and Cassandra
7 Kees van Bochove, CEO - The Hyve Kees van Bochove is founder and CEO of The Hyve, a company dedicated to the support and facilitation of open source, open standards and open data in bioinformatics and translational research. He studied Computer Science at University of Utrecht and Bioinformatics at VU University Amsterdam, for which he did his research project on lipoprotein metabolism at TNO Quality of Life in Zeist and the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University Boston. He has been lead architect and project manager in several international open source projects, including the dbnp initiative initated by the European consortia NuGO, EURECCA, Bioclaims and the Dutch consortia Netherlands Bioinformatics Centre (NBIC), Netherlands Metabolomics Centre (NMC) and Netherlands Toxicogenomics Centre (NTC). Currently, he is active in the transmart initiative, as member of the Board of Directors of transmart Foundation and leading the Foundations Architecture Working Group. TranSMART is an open source project forming a comprehensive infrastructure for translational research, governed by the transmart Foundation, with a large international community that includes the CTMM TraIT project with a.o. VUmc, ErasmusMC, UMCG and Philips Research, academic members such as Imperial College, University of Michigan, Harvard Medical School, and Johns Hopkins University, patient organizations such as Michael J Fox Foundation, major pharmaceutical companies including Janssen, Sanofi, Pfizer, Takeda and Roche, IT vendors such as Deloitte, Thomson Reuters, Oracle and IBM, and many IMI consortia including etriks, supported by the Pistoia Alliance. All these projects revolve around introducing open standards and open source software for translational research. Through his many years of experience in open source software and standards development in bioinformatics, Kees has gained a deep understanding of all aspects of collaborative open source development and open data science, including open source community building and governance, software quality and sustainability requirements, data workflows, enterprise plugin architectures, legal ramifications and practical aspects such as working in virtual teams and code merging and governance. Jean-Baptiste Cazier, Director of Centre for Computational Biology, Prof of Bioinformatics - University of Birmingham Trained in Mathematical modelling, Jean-Baptiste Cazier is a Professor of Bioinformatics with interest across the broad spectrum of Computational Biology: from Cancer Genetics, Population Genetics and Metabonomics to Swarming. After 5 years working on Population Genetics for decode Genetics in Iceland, he joined the Cancer Research UK s London Research Institute, where he worked alongside experts in most aspects of bioinformatics and biostatistics in the context of cancer. While in Oxford from 2008, he supervised the development of analytical approaches and tools for the analysis of whole genome sequencing projects (WGS500) at the Wellcome Trust Centre for Human Genetics with a special focus on immune disorders and cancers; successfully bringing afore new variants functionally associated with the development of diseases. Jean-Baptiste then joined the Department of Oncology to create a new Bioinformatics infrastructure to both provide support to the department and lead independently funded research. In 2014, Jean-Baptiste moved to the University of Birmingham taking up the new chair of Bioinformatics to create the Centre for Computational Biology (CCB). The CCB is a university-wide effort aims to promote excellence in Computational Biology, Systems Biology, and Bioinformatics across the range of fundamental and applied sciences, in both the University and allied Health Care arenas. Keith O. Elliston, President and CEO - transmart Foundation Keith O. Elliston, PhD, is a co-founder and the President and CEO of the transmart Foundation. Keith is an experienced scientist and entrepreneur with expertise in systems biology and data science, and in the development and growth of new life science and technology ventures. Keith also currently serves as the Managing Director for Seneca Creek Research, where serves and a founder, investor and advisor to various biotechnology startup and early stage companies. Previously, Keith built and managed the systems biology program for CHDI, the Huntington s disease foundation, as a fully integrated and systems-driven discovery biology program for a genetic disease of neurodegeneration. Keith has authored more than 40 peer-reviewed scientific publications, and been a contributor to more than 280,000 sequence entries in Genbank. Entrepreneurially, Keith has played a key role in the founding of more than a dozen biotech ventures; he is a co-founder and CEO for Virtual-Rx, a virtual pharma platform company; was co- founder, president, and CEO of Selventa (originally Genstruct), a venture-backed systems biology platform company; was CEO and co-founder of Viaken Systems, a venture-backed informatics service provider, and was SVP R&D and CSO for Gene Logic (Nasdaq:GLGC), among others. Keith began his career at Merck, where he built and led the bioinformatics and genomics programs, and ran the Merck Gene Index, a privately funded public genome effort that published the first sequence for 3/4 of expressed human genes. Keith has successfully built biotechnology ventures from startup through IPO, and established profitable and capital-efficient companies working both with venture capital and as a founder or advisor. Keith combines extensive experience in pharmaceutical R&D, biotechnology, information technology and data science with successful executive and team leadership into a unique set of skills that drives innovation and value. Jan-Willem Boiten, Project Manager Translation Research IT - CTMM Jan-Willem Boiten leads the Dutch national TraIT (Translational Research IT) program to organize, deploy, and manage a multi-partner IT infrastructure for data and workflow management targeted specifically at translational research. TraIT is organised as a public-private partnership with over 30 partners, and has a clear preference for the application of open-source software. Prior to joining CTMM Dr. Boiten has had several position in research IT management within Pharma (Organon/Schering Plough/ Merck).
8 WW 2015 UPCOMING STRATEGY MEETINGS CLINICAL OPERATIONS STRATEGY MEETING USA TH NOVEMBER 2015 HYATT HARBOR HOTEL, BOSTON BIOINFORMATICS STRATEGY MEETING USA TH NOVEMBER 2015 HYATT HARBOR HOTEL, BOSTON MEDICINALCHEMISTRY STRATEGY MEETING USA TH NOVEMBER 2015 HYATT HARBOR HOTEL, BOSTON 2016 UPCOMING STRATEGY MEETINGS ONCOLOGY STRATEGY MEETING EUROPE TH MARCH 2016 THE MARRIOTT HEATHROW, LONDON MEDICINALCHEMISTRY STRATEGY MEETING EUROPE TH MARCH 2016 THE MARRIOTT HEATHROW, LONDON proventa INTERNATIONAL Telephone: Telephone:
CASC Fall Meeting 2014
CASC Fall Meeting 2014 transmart and the emergent requirement for Policies regarding Open Science and Open Data to help Sustain in Translational Research Brian D. Athey, Ph.D. Michael A. Savageau Collegiate
More informationAnalyzing NGS data with clinical data: open source software for translational medicine
Analyzing NGS data with clinical data: open source software for translational medicine BASEL LIFE SCIENCE WEEK NGS FORUM SEPTEMBER 24, 2015 Kees van Bochove, CEO The Hyve Agenda 1. Introduction 2. Open
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More informationJoin our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
More informationThe Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg
The Evolution of Data Platforms in IMI Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg Three trends in technology today Ubiquity of the Internet Three trends in technology today Ubiquity
More informationTranslational research facilitating experimental medicine in dementia in the UK
Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June
More informationSEQUENCING INITIATIVE SUOMI (SISU) SYMPOSIUM SPEAKERS August 26, 2014
SEQUENCING INITIATIVE SUOMI (SISU) SYMPOSIUM SPEAKERS August 26, 2014 Professor Aarno Palotie Professor Aarno Palotie is the Research Director of the Human Genomics program at the Finnish Institute for
More informationDTL AS CROSS-SECTOR TECHNOLOGY PLATFORM
DTL AS CROSS-SECTOR TECHNOLOGY PLATFORM Enabling next generation life science research workshop Utrecht, October 23, 2013 AN INTEGRATED APPROACH TO BIG SCIENCE & DATA genomics/ngs proteomics metabolomics
More informationWorldwide Collaborations in Molecular Profiling
Worldwide Collaborations in Molecular Profiling Lillian L. Siu, MD Director, Phase I Program and Cancer Genomics Program Princess Margaret Cancer Centre Lillian Siu, MD Contracted Research: Novartis, Pfizer,
More informationBuilding a Collaborative Informatics Platform for Translational Research: Prof. Yike Guo Department of Computing Imperial College London
Building a Collaborative Informatics Platform for Translational Research: An IMI Project Experience Prof. Yike Guo Department of Computing Imperial College London Living in the Era of BIG Big Data : Massive
More informationMatteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum
Pharma R&D IT & The Cloud Matteo di Tommaso FDA-PhUSE March 2013 Vice President, Research Business Technology Chair, PRISME Forum This presentation outlines a general technology direction. Pfizer Inc has
More informationThe 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
More informationITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
More informationDigital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
More informationDr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
More informationThe University is comprised of seven colleges and offers 19. including more than 5000 graduate students.
UNC CHARLOTTE A doctoral, research-intensive university, UNC Charlotte is the largest institution of higher education in the Charlotte region. The University is comprised of seven colleges and offers 19
More informationCollabRx, Inc. (NasdaqCM: CLRX) Southern California Investor Conference August 8, 2013. Informing Next Generation Healthcare
CollabRx, Inc. (NasdaqCM: CLRX) Southern California Investor Conference August 8, 2013 Informing Next Generation Healthcare Safe Harbor This presentation and the accompanying commentary include forward-looking
More informationAnalysis of microarray gene expression data using R/BioC and web tools Organised by MolMed 12 th edition, Erasmus MC, June 25-29, 2012 vs 120618
Analysis of microarray gene expression data using R/BioC and web tools Organised by MolMed 12 th edition, Erasmus MC, June 25-29, 2012 vs 120618 Course organizers and website Program: Dr. Judith Boer Pediatric
More informationPersonalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
More informationDelivering the power of the world s most successful genomics platform
Delivering the power of the world s most successful genomics platform NextCODE Health is bringing the full power of the world s largest and most successful genomics platform to everyday clinical care NextCODE
More informationTHE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
More informationResumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
More informationThe Ohio State University College of Medicine. Biomedical Sciences Graduate Program (BSGP) The Biology of Human Disease. medicine.osu.
(BSGP) The Biology of Human Disease medicine.osu.edu/bsgp Welcome from BSGP Leadership Thank you for your interest in the at The Ohio State University Wexner Medical Center. Our goal is to train talented,
More informationTHE UNIVERSITY OF MANCHESTER PARTICULARS OF APPOINTMENT FACULTY OF MEDICAL & HUMAN SCIENCES INSTITUTE OF POPULATION HEALTH
THE UNIVERSITY OF MANCHESTER PARTICULARS OF APPOINTMENT FACULTY OF MEDICAL & HUMAN SCIENCES INSTITUTE OF POPULATION HEALTH CENTRE FOR HEALTH INFORMATICS HEALTH DATA SCIENTIST Vacancy ref: M&HS-07879 Salary:
More informationMaster of Science in Biomedical Sciences
Master of Science in Biomedical Sciences Faculty of Medicine Good health is our greatest treasure. Understanding the human body, healthy and diseased, is the stepping stone to finding tools to improving
More informationTRANSLATIONAL BIOINFORMATICS 101
TRANSLATIONAL BIOINFORMATICS 101 JESSICA D. TENENBAUM Department of Bioinformatics and Biostatistics, Duke University Durham, NC 27715 USA Jessie.Tenenbaum@duke.edu SUBHA MADHAVAN Innovation Center for
More informationNetherlands escience Center
Netherlands escience Center ICT Synergy Hub, Amsterdam Research & Innovation in the Big Data Era CWI in Bedrijf Centrum Wiskunde & Informatica Op 5 oktober 2012 Prof. dr. Jacob de Vlieg ¹ ² 1. CEO & Scientific
More informationClinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
More informationWorkshop on Establishing a Central Resource of Data from Genome Sequencing Projects
Report on the Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects Background and Goals of the Workshop June 5 6, 2012 The use of genome sequencing in human research is growing
More informationUniversity Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
More informationSymposium on Health Informatics
Symposium on Health Informatics Hosted by the Faculty of Pharmaceutical Sciences and Faculty of Medicine Tuesday, April 5, 2016 8:30 a.m. 5:30 p.m. Life Sciences Institute, LSC3 2350 Health Sciences Mall,
More informationResearch strategy and capacity development in population health science: an MRC and personal view
Research strategy and capacity development in population health science: an MRC and personal view Professor Anne Johnson, UCL Former Chair, MRC Population Health Sciences Strategy Group Foci of MRC and
More informationFACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
More informationMediSapiens Ltd. Bio-IT solutions for improving cancer patient care. Because data is not knowledge. 19th of March 2015
19th of March 2015 MediSapiens Ltd Because data is not knowledge Bio-IT solutions for improving cancer patient care Sami Kilpinen, Ph.D Co-founder, CEO MediSapiens Ltd Copyright 2015 MediSapiens Ltd. All
More informationCANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE
CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE Agenda Introduction to Cancer Research UK CRUK Stratified Medicine Programme Key Challenges and Lessons
More informationEuro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.2 Community Needs of
More informationLeading Genomics. Diagnostic. Discove. Collab. harma. Shanghai Cambridge, MA Reykjavik
Leading Genomics Diagnostic harma Discove Collab Shanghai Cambridge, MA Reykjavik Global leadership for using the genome to create better medicine WuXi NextCODE provides a uniquely proven and integrated
More informationOverview. Overarching observations
Overview Genomics and Health Information Technology Systems: Exploring the Issues April 27-28, 2011, Bethesda, MD Brief Meeting Summary, prepared by Greg Feero, M.D., Ph.D. (planning committee chair) The
More informationWhat do Birmingham postgraduates do?
1 Essential information What do Birmingham postgraduates do? School of First destinations of postgraduates Analysis of first employment destinations of postgraduates from the College of Medical and Dental
More informationEuropean Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute
European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute Justin Paschall Team Leader Genetic Variation / EGA ! European Genome-phenome
More informationThe Future of Personalized Medicine: Powered by Real World Data. Kris Joshi, PhD Global Vice President
The Future of Personalized Medicine: Powered by Real World Data Kris Joshi, PhD Global Vice President Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More informationTRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
More informationHow Big Data Is Hoping To Power Predictive Analytics
How Big Data Is Hoping To Power Predictive Analytics Date : Jun 06, 2016-07:30 AM - 10:00 AM Event URL : http:///events/how-big-data-is-hoping-to-powerpredictive-analytics-jun-2016 Organizer : New England
More informationPhD Education at Erasmus MC
PhD Education at Erasmus MC Research training in biomedical, clinical and health sciences Rita Struhkamp, Department of Research Policy FAQ s Where to start? Brochure Erasmus MC Graduate School www.erasmusmc.nl/phd
More informationDavid Altshuler, M.D., Ph.D. Deputy Director and Chief Academic Officer, Broad Institute of Harvard and MIT Cambridge, Massachusetts, U.S.
David Altshuler, M.D., Ph.D. Deputy Director and Chief Academic Officer, Broad Institute of Harvard and MIT Cambridge, Massachusetts, U.S. Endocrinologist and human geneticist David Altshuler is a professor
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationBig Data and the Data Lake. February 2015
Big Data and the Data Lake February 2015 My Vision: Our Mission Data Intelligence is a broad term that describes the real, meaningful insights that can be extracted from your data truths that you can act
More informationDiscover more, discover faster. High performance, flexible NLP-based text mining for life sciences
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge
More informationNEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES
PRESS RELEASE NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES European research centres in life sciences gather to foster excellence in research, share knowledge, and influence
More informationVision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
More informationHigh Performance Computing Initiatives
High Performance Computing Initiatives Eric Stahlberg September 1, 2015 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Frederick National Laboratory is
More informationService courses for graduate students in degree programs other than the MS or PhD programs in Biostatistics.
Course Catalog In order to be assured that all prerequisites are met, students must acquire a permission number from the education coordinator prior to enrolling in any Biostatistics course. Courses are
More informationCOMPUTATIONAL LIFE SCIENCE (MSc) GRADUATE PROGRAM
COMPUTATIONAL LIFE SCIENCE (MSc) GRADUATE PROGRAM THE PROGRAM COMPUTATIONAL LIFE SCIENCE (COMPLIFE) Over the last decades, biomedical research has become increasingly interdisciplinary in nature, focusing
More informationSharing Data from Large-scale Biological Research Projects: A System of Tripartite Responsibility
Sharing Data from Large-scale Biological Research Projects: A System of Tripartite Responsibility Report of a meeting organized by the Wellcome Trust and held on 14 15 January 2003 at Fort Lauderdale,
More informationThe College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art
GRADUATE PROGRAMS The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art research centers and experiential
More informationBiometrics: Clinical Trials and Beyond
Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane
More informationMoffitt Cancer Center, M2Gen and ConvergeHEALTH Collaboration
Moffitt Cancer Center, M2Gen and ConvergeHEALTH Collaboration Eric Padron, M.D., Section Head, Personalized Medicine and Genomics, Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute
More informationThe Cell Therapy Catapult
The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing
More informationEuro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences
Euro-BioImaging European Research Infrastructure for Imaging Technologies in Biological and Biomedical Sciences WP11 Data Storage and Analysis Task 11.1 Coordination Deliverable 11.3 Selected Standards
More information6 ELIXIR Domain Specific Services
6 ELIXIR Domain Specific Services Work stream leads: Alfonso Valencia (ES), Inge Jonassen (NO), Jose Leal (PT) Work stream members: Nils-Peder Willassen (NO), Finn Drablos (NO), Mark Viant (UK), Ferran
More informationVanderbilt University Biomedical Informatics Graduate Program (VU-BMIP) Proposal Executive Summary
Vanderbilt University Biomedical Informatics Graduate Program (VU-BMIP) Proposal Executive Summary Unique among academic health centers, Vanderbilt University Medical Center entrusts its Informatics Center
More informationPersonalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences
Personalized Medicine: Humanity s Ultimate Big Data Challenge Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences 2012 Oracle Corporation Proprietary and Confidential 2 3 Humanity
More informationBIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16
Course Director: Dr. Barry Grant (DCM&B, bjgrant@med.umich.edu) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationEXPLORE BIO SIMULATION. COMPUTATIONAL LIFE SCIENCE (MSc) GRADUATE PROGRAM
EXPLORE BIO SIMULATION COMPUTATIONAL LIFE SCIENCE (MSc) GRADUATE PROGRAM THE PROGRAM COMPUTATIONAL LIFE SCIENCE (COMPLIFE) Over the last decades, biomedical research has become increasingly interdisciplinary
More informationBalancing Big Data for Security, Collaboration and Performance
Balancing Big Data for Security, Collaboration and Performance Sai Balu Lineberger Cancer Center UNC Chapel Hill Oct 14, 2014 About UNC Oldest Public University -1793 Top 5 Public University. 46th World
More informationBig data in cancer research : DNA sequencing and personalised medicine
Big in cancer research : DNA sequencing and personalised medicine Philippe Hupé Conférence BIGDATA 04/04/2013 1 - Titre de la présentation - nom du département émetteur et/ ou rédacteur - 00/00/2005 Deciphering
More informationGraduate Program Objective #1 Course Objectives
1 Graduate Program Objective #1: Integrate nursing science and theory, biophysical, psychosocial, ethical, analytical, and organizational science as the foundation for the highest level of nursing practice.
More informationPROVENTA INTERNATIONAL INNOVATION. Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products
INNOVATION SPOTLIGHT SESSION Strategies for Transforming Safety, Regulatory, and Benefit-Risk Management of Established Products WEDNESDAY 4TH NOVEMBER 2015 Hyatt Regency, Princeton, NJ PROVENTA INTERNATIONAL
More informationStand Up To Cancer and the Dutch Cancer Society Announce New Dream Team Grant Recipients
For Immediate Release: Nov. 12, 2013 Stand Up To Cancer and the Dutch Cancer Society Announce New Dream Team Grant 6 Million-Euro Grant Over Four Years Will Fund Research Focusing on Tumor Organoids PHILADELPHIA
More informationMBA. Master. Market Access. Part-time berufsbegleitend. Pharmacovigilance. Strategic Management. Regulatory Affairs.
master of Pharma BUSINESS ADMINISTRATION MBA Part-time berufsbegleitend Master of Pharma BUSINESS ADMINISTRATION Health Economics Corporate Finance Strategic Management Regulatory Affairs Production Market
More informationProvidence- OHSU Informatics Course
Providence- OHSU Course Logistics, Detailed Curriculum, Learning Objectives, and Other Information William Hersh, M.D. Department of Medical & Clinical Epidemiology Oregon Health & Science University Course
More informationBig Data in Biobanking towards targeted medicine
Big Data in Biobanking towards targeted medicine Ronald Stolk Professor Clinical Epidemiology, UMCG Board member Parelsnoer Institute Chief Scientific Officer LifeLines What is a biobank? Systematic collection
More informationOPKO Health to Acquire Bio-Reference Laboratories
OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition
More informationNew Investigators. 2012 report
New Investigators 2012 report Summary Cancer Research UK has a strong portfolio of fellowships to support new researchers at the start of their independent careers. We currently support our new investigators
More information22 nd edition. Welcome,
22 nd edition Welcome, The Amsterdam International Medical Summer School (AIMSS) is an annual event, organized by the Academic Medical Center University of Amsterdam (AMC-UvA) in cooperation with the Amsterdam
More informationThe NeurOmics team at a recent project meeting
Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work
More informationBiomedical Informatics: Its Scientific Evolution and Future Promise. What is Biomedical Informatics?
Biomedical : Its Scientific Evolution and Edward H. Shortliffe, MD, PhD Professor of Biomedical Arizona State University Professor of Basic Medical Sciences and of Medicine University of Arizona College
More informationThe Physics Entrepreneurship Program at Case Western Reserve University
The Physics Entrepreneurship Program at Case Western Reserve University Cyrus C. Taylor Dept. of Physics Case Western Reserve University Cleveland, OH 44106-7079 cct@po.cwru.edu Introduction and Overview
More informationBIOMEDICAL INFORMATICS Doctor of Philosophy
BIOMEDICAL INFORMATICS Doctor of Philosophy The PhD Program in Biomedical Informatics at the University of Cincinnati (UC) leverages partnerships between three leading institutions: Cincinnati Children
More informationORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS
ORACLE HEALTH SCIENCES INFORM ADVANCED MOLECULAR ANALYTICS INCORPORATE GENOMIC DATA INTO CLINICAL R&D KEY BENEFITS Enable more targeted, biomarker-driven clinical trials Improves efficiencies, compressing
More informationBuilding Commercial Software. It has to work 100% of the time.
Building Commercial Software It has to work 100% of the time. Presenters SPI Software: Jeff Wilder: VP Customer Services Steve Schmidt: CFO Preclara: Jack Karabees: CEO U Innovation Bob Williamson: Entrepreneur
More informationDutch Techcentre for Life Sciences
Dutch Techcentre for Life Sciences next generation life science technology research infrastructure : cross-sector technology initiative Nieuwegein, 19 december 2011 Ruben Kok, Barend Mons, Jaap Heringa,
More informationBIOSCIENCES COURSE TITLE AWARD
COURSE TITLE AWARD BIOSCIENCES As a Biosciences undergraduate student at the University of Westminster, you will benefit from some of the best teaching and facilities available. Our courses combine lecture,
More informationFind the signal in the noise
Find the signal in the noise Electronic Health Records: The challenge The adoption of Electronic Health Records (EHRs) in the USA is rapidly increasing, due to the Health Information Technology and Clinical
More informationThe Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins
The Future of the Electronic Health Record Gerry Higgins, Ph.D., Johns Hopkins Topics to be covered Near Term Opportunities: Commercial, Usability, Unification of different applications. OMICS : The patient
More informationGroundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
More informationWhat is the SynbiCITE 4-Day MBA?
SynbiCITE 4 day More Business Acumen : Developing Entrepreneurship in Synthetic Biology Building a Synthetic Biology-Rich Biotech Business from Scratch 14-18 December 2015 Imperial College London What
More informationThe Pre-Medical Program. Start your career in medicine at University College Roosevelt. www.ucr.nl
The Pre-Medical Program Start your career in medicine at University College Roosevelt www.ucr.nl University College Roosevelt Pre-Medical Program University College Roosevelt (UCR) is the international
More informationERA-Net COFUND Research Programmes on Rare Diseases (E-RARE)
Bologna 15 Dicembre 2014 ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE) The Role of RER-ASSR Antonio Addis Research Governance Area Agenzia Sanitaria e Sociale Regionale How do Regions might
More informationInnovation in the LIS: Implications for Design, Procurement and Management
Innovation in the LIS: Implications for Design, Procurement and Management Ulysses J. Balis, M.D. Director, Division of Pathology Informatics & Director, Pathology Informatics Fellowship Program Department
More informationAttacking the Biobank Bottleneck
Attacking the Biobank Bottleneck Professor Jan-Eric Litton BBMRI-ERIC BBMRI-ERIC Big Data meets research biobanking Big data is high-volume, high-velocity and highvariety information assets that demand
More informationPharmD Postdoctoral Fellowship Program
Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the
More informationMaster of Science in Artificial Intelligence
Master of Science in Artificial Intelligence Options: Engineering and Computer Science (ECS) Speech and Language Technology (SLT) Big Data Analytics (BDA) Faculty of Engineering Science Faculty of Science
More informationProgram Overview. Updated 06/13
Program Overview Biomedical Informatics is an interdisciplinary science that involves both the conceptual and practical tools from diverse disciplines for the understanding, invention, generation and propagation
More informationConditions for Accreditation as (Basic) Pharmacologist
NEDERLANDSE VERENIGING VOOR FARMACOLOGIE DUTCH PHARMACOLOGICAL SOCIETY Conditions for Accreditation as (Basic) Pharmacologist 1. Introduction The Dutch Pharmacological Society (DPS) is the organization
More informationSEBP2015. S i n o - E u r o B i o P a r t n e r i n g 中 欧 生 物 医 药 项 目 合 作. Industry Insight Innovation Fostering Bio-Investment Roadshow & Partnering
Thursday May 14 th, 2015 Shanghai, China a S i n o - E u r o B i o P a r t n e r i n g 中 欧 生 物 医 药 项 目 合 作 Industry Insight Innovation Fostering Bio-Investment Roadshow & Partnering INTRODUCTION A partnering
More informationTIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials
TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials Pharmaceutical leader deploys TIBCO Spotfire enterprise analytics platform across its drug discovery organization
More informationMolecular Biotechnology Master s Degree Program
> APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one
More informationMSD Information Technology Global Innovation Center. Digitization and Health Information Transparency
MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology
More information